U.S. Polymerase Chain Reaction Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	145 Pages	Data Bridge Market Research	January, 2023	DAABD18146426

Best Price Guarantee
Price	from $2,500
Length	145 Pages
Publisher	Data Bridge Market Research
Published Date	January, 2023
SKU	DAABD18146426

U.S. Polymerase Chain Reaction Market - Industry Trends and Forecast to 2030

U.S. polymerase chain reaction market is expected to reach USD 11,168.47 million by 2030 from USD 4,465.81 million in 2022, growing at a CAGR of 12.2% during the forecast period of 2023 to 2030.

Market Segmentation
By Product Type (Reagents, Instruments, Consumables, Software, and Services), Method (Real-Time PCR, Reverse-Transcriptase (RT) PCR, Conventional PCR, Multiplex PCR, Nested PCR, Hot Start PCR, Long-Range PCR, Assembly PCR, Inverse PCR, and Others), Application (Clinical, Life Science and Related Researches, Forensic Science, Environmental Microbiology and Other), End User (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Organizations, Forensic Laboratories, Reference Laboratories, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) Country (U.S.) - Industry Trends and Forecast to 2030

Overview of U.S. Polymerase Chain Reaction Market Dynamics

Driver

• Rise in the availability of PCR diagnostics

Restrain

• Limitation analyzing novel complex devices
Opportunity

• Rising research and development activities

Market Players

Some of the key players operating in the U.S. polymerase chain reaction market are
• Beckman Coulter, Inc
• F. Hoffmann-La Roche Ltd
• Promega Corporation
• Illumina, Inc
• Bio-Rad Laboratories, Inc
• QIAGEN
• Merck KGaA
• GenScript
• Thermo Fisher Scientific Inc
• PerkinElmer Inc
• Enzo Life Sciences, Inc.
• bioMérieux Inc
• Takara Bio Inc.
• LGC biosearch technologies
• Meridian bioscience, Inc.,
• luminex corporation
• Agilent Technologies, Inc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. These report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The U.S. Polymerase Chain Reaction Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Product Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestle Analysis; 4.2 Porter's Five Forces Model; 4.3 Installation Base; 4.4 Cost Analysis; 4.5 Value Chain Analysis; 4.6 Healthcare Economy; 4.6.1 Healthcare Expenditure; 4.6.2 Capital Expenditure; 4.6.3 Capex Trends; 4.6.4 Capex Allocations; 4.6.5 Funding Sources; 4.6.6 Industry Benchmarks; 4.6.7 Gdp Ratio In Overall Gdp; 4.6.8 Healthcare System Structure; 4.6.9 Government Policies; 4.6.10 Economic Development; 4.7 Industry Insights; 4.7.1 Micro And Macroeconomic Factors; 4.7.2 Penetration And Growth Prospect Mapping; 4.7.3 Key Pricing Strategies; 4.8 Technology Roadmap
5 Regulatory Compliance: 5.1 Regulatory Authorities; 5.2 Regulatory Classifications; 5.3 Regulatory Submissions; 5.4 International Harmonization; 5.5 Compliance And Quality Management Scenario; 5.6 Regulatory Challenges And Strategy
6 Market Overview, U.S. Polymerase Chain Reaction Market: 6.1 Drivers; 6.1.1 Rise In The Availability Of Pcr Diagnostics; 6.1.2 Increasing Application Of Pcr; 6.1.3 Increasing Demand For Personalized Medicine; 6.2 Restraints; 6.2.1 Limitations While Analyzing The Novel Complex Device; 6.2.2 Long Approval Procedure; 6.3 Opportunities; 6.3.1 Government Initiatives To Implement Screening Programs For Various Diseases; 6.3.2 Rising Research And Development Activities; 6.4 Challenges; 6.4.1 Increase In The Product Recalls; 6.4.2 High Cost Of Pcr Medical Device Development 59
7 U.S. Polymerase Chain Reaction Market, By Product Type: 7.1 Overview; 7.2 Reagents; 7.2.1 Dna Or Pcr Templates; 7.2.2 Dna Polymerase I Enzyme; 7.2.2.1 Taq Dna Polymerase; 7.2.2.2 High-fidelity Dna Polymerase; 7.2.2.3 Green Taq Dna Polymerase; 7.2.2.4 Hot Start Taq Dna Polymerase; 7.2.2.5 Proofreading Dna Polymerase; 7.2.2.6 Others; 7.2.3 Primers; 7.2.4 Deoxynucleotide Triphosphates (Dntps); 7.2.5 Pcr Buffers; 7.2.5.1 Tris-hcl; 7.2.5.2 Potassium Chloride (Kcl); 7.2.5.3 Magnesium Chloride; 7.2.6 Master Mix Or Pcr Kit; 7.2.7 Probes; 7.2.8 Anti-taq Dna Polymerase Antibody; 7.2.9 Digital Pcr Supermixes; 7.2.10 Others; 7.3 Instruments; 7.3.1 By Type; 7.3.1.1 Digital Pcr; 7.3.1.1.1 Digital Pcr(Ddpcr); 7.3.1.1.2 Chip Based Digital Pcr; 7.3.1.1.3 Beaming Digital Pcr; 7.3.1.2 Real Time Pcr; 7.3.1.3 Conventional Pcr; 7.3.1.4 Others; 7.3.2 By Modality; 7.3.2.1 Standlone; 7.3.2.2 Handheld; 7.3.2.3 Portable; 7.4 Consumables; 7.4.1 Pcr Tubes And Caps; 7.4.2 Pcr Strips; 7.4.3 Pcr Well Plates; 7.4.4 Strip Tubes; 7.4.5 Plate Seals; 7.4.6 Cartridges And Gaskets; 7.4.7 Others; 7.5 Software And Services
8 U.S. Polymerase Chain Reaction Market, By Method: 8.1 Overview; 8.2 Real-time Pcr; 8.3 Reverse-transcriptase(Rt) Pcr; 8.4 Conventional Pcr; 8.5 Multiplex Pcr; 8.6 Nested Pcr; 8.7 Hot Start Pcr; 8.8 Long-range Pcr; 8.9 Assembly Pcr; 8.10 Inverse Pcr; 8.11 Others
9 U.S. Polymerase Chain Reaction Market, By Application: 9.1 Overview; 9.2 Clinical; 9.2.1 Oncology Testing; 9.2.2 Infectious Disease Testing; 9.2.2.1 Human Papillomavirus; 9.2.2.2 Hiv; 9.2.2.3 Hcv; 9.2.2.4 Hepatitis B Virus; 9.2.2.5 Others; 9.2.3 Transplant Diagnostics; 9.2.4 Paternity Testing; 9.2.5 Others; 9.3 Life Science And Related Researches; 9.3.1 Microbiology; 9.3.2 Molecular And Cell Biology; 9.3.3 Others; 9.4 Forensic Science; 9.4.1 Dna Typing; 9.4.2 Dna Testing; 9.4.3 Genetic Fingerprinting; 9.5 Environmental Microbiology; 9.5.1 Detection Of Targeted Microorganisms; 9.5.2 Quantification Of Microbial Population; 9.5.3 Microbial Community Analysis; 9.5.4 Detection Of Microbial Pathogen; 9.5.5 Detection Of Gene Expression In The Environment; 9.5.6 Detection Of Indictor Microorganisms In Water; 9.5.7 Environmental Dna Analysis; 9.5.8 Others; 9.6 Others
10 U.S. Polymerase Chain Reaction Market, By End User: 10.1 Overview; 10.2 Pharmaceutical And Biotechnology Companies; 10.3 Hospitals And Clinics; 10.3.1 Private; 10.3.1.1 Tier 1; 10.3.1.2 Tier 2; 10.3.1.3 Tier 3; 10.3.2 Public; 10.3.2.1 Tier 1; 10.3.2.2 Tier 2; 10.3.2.3 Tier 3; 10.4 Diagnostic Laboratories; 10.5 Academic And Research Organizations; 10.6 Forensic Laboratories; 10.7 Reference Laboratories; 10.8 Others
11 U.S. Polymerase Chain Reaction Market, By Distribution Channel: 11.1 Overview; 11.2 Direct Tender; 11.3 Retail Sales; 11.4 Others 106
12 U.S. Polymerase Chain Reaction Market: Company Landscape: 12.1 Company Share Analysis: U.S.
13 Swot Analysis
14 U.S. Polymerase Chain Reaction Market, Company Profile: 14.1 Merck Kgaa; 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Product Portfolio; 14.1.4 Recent Developments; 14.2 F. Hoffmann- La Roche Ltd; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Product Portfolio; 14.2.4 Recent Development; 14.3 Bio-rad Laboratories, Inc; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Product Portfolio; 14.3.4 Recent Developments; 14.4 Qiagen; 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Product Portfolio; 14.4.4 Recent Developments; 14.5 Agilent Technologies, Inc.; 14.5.1 Company Profile; 14.5.2 Revenue Analysis; 14.5.3 Product Portfolio; 14.5.4 Recent Development; 14.6 Abbott; 14.6.1 Company Snapshot; 14.6.2 Revenue Analysis; 14.6.3 Product Portfolio; 14.6.4 Recent Development; 14.7 Beckman Coulter, Inc.; 14.7.1 Company Snapshot; 14.7.2 Product Portfolio; 14.7.3 Recent Developments; 14.8 Biomeriux; 14.8.1 Company Profile; 14.8.2 Revenue Analysis; 14.8.4 Recent Development; 14.9 Enzo Life Sciences, Inc.; 14.9.1 Company Snapshot; 14.9.2 Product Portfolio; 14.9.3 Recent Development; 14.10 Genscript; 14.10.1 Company Snapshot; 14.10.2 Revenue Analysis; 14.10.3 Product Portfolio; 14.10.4 Recent Developments; 14.11 Illumina Inc; 14.11.1 Company Snapshot; 14.11.2 Revenue Analysis; 14.11.3 Product Portfolio; 14.11.4 Recent Development; 14.12 Lgc Biosearch Technologies; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Development; 14.13 Luminex Corporation; 14.13.1 Company Snapshot; 14.13.2 Product Portfolio; 14.13.3 Recent Development; 14.14 Meridian Bioscience Inc; 14.14.1 Company Profile; 14.14.2 Revenue Analysis; 14.14.4 Recent Development; 14.15 Perkinelmer Inc; 14.15.1 Company Profile; 14.15.2 Revenue Analysis; 14.15.4 Recent Development; 14.16 Promega Corporation; 14.16.1 Company Snapshot; 14.16.2 Product Portfolio
List Of Tables: Table 1 U.S. Polymerase Chain Reaction Market, By Product Type, 2021-2030 (Usd Million); Table 2 U.S. Reagents In Polymerase Chain Reaction Market, By Product Type, 2021-2030 (Usd Million); Table 3 U.S. Dna Polymerase I Enzyme In Polymerase Chain Reaction Market, By Reagents, 2021-2030 (Usd Million); Table 4 U.S. Pcr Buffers In Polymerase Chain Reaction Market, By Reagents, 2021-2030 (Usd Million); Table 5 U.S. Instruments In Polymerase Chain Reaction Market, By Type, 2021-2030 (Usd Million); Table 6 U.S. Digital Pcr In Polymerase Chain Reaction Market, By Technology, 2021-2030 (Usd Million); Table 7 U.S. Instruments In Polymerase Chain Reaction Market, By Modality, 2021-2030 (Usd Million); Table 8 U.S. Consumables In Polymerase Chain Reaction Market, By Product Type, 2021-2030 (Usd Million); Table 9 U.S. Polymerase Chain Reaction Market, By Method, 2021-2030 (Usd Million); Table 10 U.S. Polymerase Chain Reaction Market, By Application, 2021-2030 (Usd Million); Table 11 U.S. Clinical In Polymerase Chain Reaction Market, By Application, 2021-2030 (Usd Million); Table 12 U.S. Infectious Disease Testing In Polymerase Chain Reaction Market, By Application, 2021-2030 (Usd Million); Table 13 U.S. Life Science And Related Researches In Polymerase Chain Reaction Market, By Application, 2021-2030 (Usd Million); Table 14 U.S. Forensic Science In Polymerase Chain Reaction Market, By Application, 2021-2030 (Usd Million); Table 15 U.S. Environmental Microbiology In Polymerase Chain Reaction Market, By Application, 2021-2030 (Usd Million); Table 16 U.S. Polymerase Chain Reaction Market, By End User, 2018-2030 (Usd Million); Table 17 U.S. Hospitals And Clinics In Polymerase Chain Reaction Market, By End Users, 2021-2030 (Usd Million); Table 18 U.S. Private In Polymerase Chain Reaction Market, By End Users, 2021-2030 (Usd Million); Table 19 U.S. Public In Polymerase Chain Reaction Market, By End Users, 2021-2030 (Usd Million); Table 20 U.S. Polymerase Chain Reaction Market, By Distribution Channel, 2018-2030 (Usd Million)
List Of Figures: Figure 1 U.S. Polymerase Chain Reaction Market: Segmentation; Figure 2 U.S. Polymerase Chain Reaction Market: Data Triangulation; Figure 3 U.S. Polymerase Chain Reaction Market: Droc Analysis; Figure 4 U.S. Polymerase Chain Reaction Market: Global Vs Regional Market Analysis; Figure 5 U.S. Polymerase Chain Reaction Market: Company Research Analysis; Figure 6 U.S. Polymerase Chain Reaction Market: Interview Demographics; Figure 7 U.S. Polymerase Chain Reaction Market: Dbmr Market Position Grid; Figure 8 U.S. Polymerase Chain Reaction Market: Market End User Coverage Grid; Figure 9 U.S. Polymerase Chain Reaction Market: Vendor Share Analysis; Figure 10 U.S. Polymerase Chain Reaction Market: Segmentation; Figure 11 Increasing Application Of Pcr Is Expected To Drive The Growth Of The U.S. Polymerase Chain Reaction Market In The Forecast Period; Figure 12 The Reagents Segment Is Expected To Account For The Largest Share Of The U.S. Polymerase Chain Reaction Market In 2023 And 2030; Figure 13 Drivers, Restraints, Opportunities And Challenges Of The U.S. Polymerase Chain Reaction Market; Figure 14 U.S. Polymerase Chain Reaction Market: By Product Type, 2022; Figure 15 U.S. Polymerase Chain Reaction Market: By Product Type, 2023-2030 (Usd Million); Figure 16 U.S. Polymerase Chain Reaction Market: By Product Type, Cagr (2023-2030); Figure 17 U.S. Polymerase Chain Reaction Market: By Product Type, Lifeline Curve; Figure 18 U.S. Polymerase Chain Reaction Market: By Method, 2022; Figure 19 U.S. Polymerase Chain Reaction Market: By Method, 2023-2030 (Usd Million); Figure 20 U.S. Polymerase Chain Reaction Market: By Method, Cagr (2023-2030); Figure 21 U.S. Polymerase Chain Reaction Market: By Method, Lifeline Curve; Figure 22 U.S. Polymerase Chain Reaction Market: By Application, 2022; Figure 23 U.S. Polymerase Chain Reaction Market: By Application, 2023-2030 (Usd Million); Figure 24 U.S. Polymerase Chain Reaction Market: By Application, Cagr (2023-2030); Figure 25 U.S. Polymerase Chain Reaction Market: By Application, Lifeline Curve; Figure 26 U.S. Polymerase Chain Reaction Market: By End User, 2022; Figure 27 U.S. Polymerase Chain Reaction Market: By End User, 2023-2030 (Usd Million); Figure 28 U.S. Polymerase Chain Reaction Market: By End User, Cagr (2023-2030); Figure 29 U.S. Polymerase Chain Reaction Market: By End User, Lifeline Curve; Figure 30 U.S. Polymerase Chain Reaction Market: By Distribution Channel, 2022; Figure 31 U.S. Polymerase Chain Reaction Market: By Distribution Channel, 2023-2030 (Usd Million); Figure 32 U.S. Polymerase Chain Reaction Market: By Distribution Channel, Cagr (2023-2030); Figure 33 U.S. Polymerase Chain Reaction Market: By Distribution Channel, Lifeline Curve; Figure 34 U.S. Polymerase Chain Reaction Market: Company Share 2022 (%)